H-1B filings

Does Ocular Therapeutix, Inc. sponsor H-1B?

Yes, according to public filings. Ocular Therapeutix, Inc. filed 11 H-1B labor condition applications in fiscal years 2024-2026, including 4 in fiscal year 2026.

USCIS approved 11 H-1B petitions for this employer in fiscal years 2024-2026.

This page uses public government filings. A filing does not guarantee that the employer will sponsor you. This information is not legal advice.

Status on October 22, 2026: USCIS does not collect the $100,000 payment on new H-1B petitions for workers outside the U.S. while court orders stand. Appeals are pending, so this can change. USCIS H-1B FAQ

Labor condition applications by fiscal year

Fiscal yearFiledCertifiedWorkers
2026444
2025666
2024111

An employer files a labor condition application with the Department of Labor before it files an H-1B petition. A certified application is not an approved visa. The U.S. fiscal year runs from October 1 to September 30.

USCIS decisions on H-1B petitions by fiscal year

Fiscal yearNew: approvedNew: deniedContinuing: approvedContinuing: denied
20261030
20253030
20240010

New petitions are for first H-1B employment. Continuing petitions are for extensions and for workers who change employers.

Typical roles and wage ranges

Job titleApplicationsWage range per yearMedian
Senior Manager, Regulatory Affairs2$160,000 - $193,000$193,000
Clinical Scientist2$104,000 - $104,000$104,000
Sr. Manager, Medical And Scientific Publications1$179,000 - $179,000$179,000
Senior Computer Systems Validation Engineer1$135,000 - $135,000$135,000
Senior Engineer1$140,000 - $140,000$140,000
Manager, QA Compliance1$140,000 - $140,000$140,000
Quality Analyst 1 “ Microbiology1$62,220 - $62,220$62,220
Senior Manager, Strategic Sourcing1$142,012 - $142,012$142,012
Validation Engineer III1$98,405 - $98,405$98,405

Wages are the rates the employer stated in its applications. Actual pay can differ.

Top locations

LocationApplications
Bedford, MA8
Nashua, NH2
Tewksbury, MA1

Sources

Data release 2026q3, built on October 23, 2026.